BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27223614)

  • 1. Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.
    Ramasawmy R; Johnson SP; Roberts TA; Stuckey DJ; David AL; Pedley RB; Lythgoe MF; Siow B; Walker-Samuel S
    PLoS One; 2016; 11(5):e0156162. PubMed ID: 27223614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a combined ultrasound and bioluminescence imaging system with magnetic resonance imaging in orthotopic pancreatic murine tumors.
    Rojas JD; Joiner JB; Velasco B; Bautista KJB; Aji AM; Moore CJ; Beaumont NJ; Pylayeva-Gupta Y; Dayton PA; Gessner RC; Czernuszewicz TJ
    Sci Rep; 2022 Jan; 12(1):102. PubMed ID: 34996939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal approach to assess tumour vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumour xenografts.
    Arteaga-Marrero N; Rygh CB; Mainou-Gomez JF; Nylund K; Roehrich D; Heggdal J; Matulaniec P; Gilja OH; Reed RK; Svensson L; Lutay N; Olsen DR
    Contrast Media Mol Imaging; 2015; 10(6):428-37. PubMed ID: 26010530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis.
    Black PC; Shetty A; Brown GA; Esparza-Coss E; Metwalli AR; Agarwal PK; McConkey DJ; Hazle JD; Dinney CP
    BJU Int; 2010 Dec; 106(11):1799-804. PubMed ID: 20500508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
    Haldorsen IS; Popa M; Fonnes T; Brekke N; Kopperud R; Visser NC; Rygh CB; Pavlin T; Salvesen HB; McCormack E; Krakstad C
    PLoS One; 2015; 10(8):e0135220. PubMed ID: 26252891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of imaging techniques for the assessment of tumour progression in an orthotopic rat model of malignant pleural mesothelioma†.
    Meerang M; Boss A; Kenkel D; Broggini-Tenzer A; Bérard K; Lauk O; Arni S; Weder W; Opitz I
    Eur J Cardiothorac Surg; 2015 Jan; 47(1):e34-41. PubMed ID: 25344922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.
    Song HT; Jordan EK; Lewis BK; Liu W; Ganjei J; Klaunberg B; Despres D; Palmieri D; Frank JA
    J Transl Med; 2009 Oct; 7():88. PubMed ID: 19840404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of orthotopic tumour models using ultrasound-guided intrahepatic injection.
    McVeigh LE; Wijetunga I; Ingram N; Marston G; Prasad R; Markham AF; Coletta PL
    Sci Rep; 2019 Jul; 9(1):9904. PubMed ID: 31289364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer.
    Ravoori MK; Margalit O; Singh S; Kim SH; Wei W; Menter DG; DuBois RN; Kundra V
    Sci Rep; 2019 Apr; 9(1):6100. PubMed ID: 30988343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality cellular and molecular imaging of concomitant tumour enhancement in a syngeneic mouse model of breast cancer metastasis.
    Parkins KM; Dubois VP; Hamilton AM; Makela AV; Ronald JA; Foster PJ
    Sci Rep; 2018 Jun; 8(1):8930. PubMed ID: 29895974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo MRI for effective non-invasive detection and follow-up of an orthotopic mouse model of lung cancer.
    Bianchi A; Dufort S; Fortin PY; Lux F; Raffard G; Tassali N; Tillement O; Coll JL; Crémillieux Y
    NMR Biomed; 2014 Aug; 27(8):971-9. PubMed ID: 24913958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive in vivo imaging for liver tumour progression using an orthotopic hepatocellular carcinoma model in immunocompetent mice.
    Wang Q; Luan W; Goz V; Burakoff SJ; Hiotis SP
    Liver Int; 2011 Sep; 31(8):1200-8. PubMed ID: 21745281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation.
    Deng Z; Xu X; Garzon-Muvdi T; Xia Y; Kim E; Belcaid Z; Luksik A; Maxwell R; Choi J; Wang H; Yu J; Iordachita I; Lim M; Wong JW; Wang KK
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):612-620. PubMed ID: 31738948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer.
    Snyder CS; Kaushal S; Kono Y; Tran Cao HS; Hoffman RM; Bouvet M
    BMC Cancer; 2009 Apr; 9():106. PubMed ID: 19351417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements.
    Ayers GD; McKinley ET; Zhao P; Fritz JM; Metry RE; Deal BC; Adlerz KM; Coffey RJ; Manning HC
    J Ultrasound Med; 2010 Jun; 29(6):891-901. PubMed ID: 20498463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging.
    Thalheimer A; Korb D; Bönicke L; Wiegering A; Mühling B; Schneider M; Koch S; Riedel SS; Germer CT; Beilhack A; Brändlein S; Otto C
    J Surg Res; 2013 Nov; 185(1):143-51. PubMed ID: 23998649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Optimal Orthotopic Mouse Model for Human Colorectal Cancer Primary Tumor Growth and Spontaneous Metastasis.
    Hite N; Klinger A; Hellmers L; Maresh GA; Miller PE; Zhang X; Li L; Margolin DA
    Dis Colon Rectum; 2018 Jun; 61(6):698-705. PubMed ID: 29722728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
    Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
    BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
    Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
    Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy.
    Inoue Y; Izawa K; Tojo A; Nomura Y; Sekine R; Oyaizu N; Ohtomo K
    Exp Hematol; 2007 Mar; 35(3):407-15. PubMed ID: 17309821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.